How is the Entrada Therapeutics Inc today?

The Entrada Therapeutics Inc today is trading in the down by -0.57% at 7.02.

How has Entrada Therapeutics Inc performed historically?

The Entrada Therapeutics Inc is currently trading down -0.57% on an intraday basis in the past week the index fell -0.14%. The index has been down -29.09% in the past quarter and fell -50.21% in the past year. You can view this in the overview section.

What is Entrada Therapeutics Inc Annual Revenue?

Entrada Therapeutics Inc Annual Revenue rose 63.38%, in the last year to $210.78 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Entrada Therapeutics Inc Annual Net Profit?

Entrada Therapeutics Inc Annual Net Profit rose 1,081.69% in the last year to $65.63 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Entrada Therapeutics Inc Price to Earning Ratio?

Entrada Therapeutics Inc Price to Earning Ratio is 10.75, higher than its sector PE ratio of 4.56.

What is Entrada Therapeutics Inc Stock Price?

Entrada Therapeutics Inc Stock Price fell 50.21% and underperformed its sector by 97.09% in the past year.

What is Entrada Therapeutics Inc Quarterly Revenue?

Entrada Therapeutics Inc Quarterly Revenue fell 65.23% YoY to $20.56 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Entrada Therapeutics Inc Quarterly Net profit?

Entrada Therapeutics Inc Quarterly Net profit fell 173.84% YoY to $17.35 M. Its sector's average net profit growth YoY for the quarter was -236.05%.

What is Entrada Therapeutics Inc Debt to Equity Ratio?

Entrada Therapeutics Inc Debt to Equity Ratio of 0.14 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Entrada Therapeutics Inc Return on Equity(ROE)?

Entrada Therapeutics Inc Return on Equity(ROE) for the last financial year was 19.56%, in the normal range of 10% to 20%.

What is Entrada Therapeutics Inc Mutual Fund Holding?

Entrada Therapeutics Inc Mutual Fund Holding decreased by 1.22% in the last quarter to 31.05.

What is Entrada Therapeutics Inc Institutional Holding?

Entrada Therapeutics Inc Institutional Holding decreased by 0.81% in the last quarter to 79.78.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
ENTRADA THERAPEUTICS INC

Entrada Therapeutics Inc XNAS: TRDA

Entrada Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Entrada Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Entrada Therapeutics Inc
Rating: 1.77809725
Author: Trendlyne DVM scores

Slowing Down Stock

about

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosoma...

7.02 -0.04 (-0.57%)

New 52W Low today

96,990

XNAS Volume

XNAS 26 Jun, 2025 5:30 PM (EDT)

Medium Financial Strength

38.9 / 100

Mid Valuation

42.5 / 100

Technically Bearish

22.0 / 100

Slowing Down Stock These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time. View Similar Embed DVM

1Yr Price target upside is 192%

2 analysts

Entrada Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Entrada Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosoma...

New 52W Low today

SWOT Analysis

Entrada Therapeutics Inc Live Price Chart

Entrada Therapeutics Inc FAQ

How is Entrada Therapeutics Inc today?

Entrada Therapeutics Inc today is trading in the red, and is down by -0.57% at 7.02.

How has Entrada Therapeutics Inc performed historically?

Entrada Therapeutics Inc is currently trading down -0.57% on an intraday basis. In the past week the stock fell -0.14%. stock has been down -29.09% in the past quarter and fell -50.21% in the past year. You can view this in the overview section.